-
Something wrong with this record ?
Our experiences with measurement of new potential biomarkers in the diagnosis of latent forms of myocardial ischemia
D. Stejskal, B. Lacnak, M. Karpisek, M. Kaminek
Language English Country Czech Republic
Document type Journal Article
NLK
Directory of Open Access Journals
from 2001
Free Medical Journals
from 1998
ROAD: Directory of Open Access Scholarly Resources
from 2001
PubMed
17426785
DOI
10.5507/bp.2006.034
Knihovny.cz E-resources
- MeSH
- Biomarkers blood MeSH
- Myocardial Ischemia diagnosis MeSH
- Tomography, Emission-Computed, Single-Photon MeSH
- Clusterin blood MeSH
- Myosin Light Chains blood MeSH
- Humans MeSH
- Lithostathine blood MeSH
- Sensitivity and Specificity MeSH
- Check Tag
- Humans MeSH
- Male MeSH
- Female MeSH
- Publication type
- Journal Article MeSH
BACKGROUND: The need for a laboratory marker of myocardial ischemia has been alluded to for at least the last decade. AIM: The aim of this study was to evaluate the diagnostic importance of the myosin light chain-1 (MLC-1), clusterin and Reg-Ialpha in patients with suspected myocardial ischemia. METHODS: A group of 176 at high-risk for myocardial ischemia subjects was evaluated and divided into two subgroups using myocardial SPECT (Single Photon Emission Computed Tomography) - individuals with and without signs of myocardial ischemia. Laboratory markers in venous blood were repeatedly examined in all subjects: a) immediately prior to SPECT: C-reactive protein, Haemoglobin, Hematocrite, Lactate, MLC-1, Clusterin, Reg-Ialpha b) at subjective maximum: Hb, Htc, lactate, MLC-1, Clusterin, Reg-Ialpha c) 30 min after stress levels reached their peak: MLC-1, Clusterin, Reg-Ialpha and d) 60 min after peak stress levels: MLC-1, Clusterin, Reg-Ialpha. RESULTS: Patients were divided into subgroups according to their positive and negative SPECT results (positive: n = 37; negative: n = 139). MLC-1 values were different for all 4 blood collections. An increase in MLC-1 > 2.2 mg/l showed 64 % sensitivity and 88 % specificity for the diagnosed presence of myocardial ischemia (AUC 0.81; LR+ 5.9; PPV+ 68 % and NPV- 87 %). There was no significant difference between the groups in terms of Clusterin and Reg-Ialpha for any of the sampling periods. CONCLUSIONS: High diagnostic efficacy of detectable MLC-1 was shown for the diagnosis of latent myocardial ischemia. Measurement of serum Clusterin or Reg-Ialpha did not sufficient for the diagnosis of latent myocardial ischemia.
Department of Laboratory Medicine and Internal Department Sternberk Hospital
Department of Nuclear Medicine Faculty of Medicine and Dentistry Palacky University Olomouc
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc13003672
- 003
- CZ-PrNML
- 005
- 20130213090509.0
- 007
- ta
- 008
- 130128s2006 xr d f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.5507/bp.2006.034 $2 doi
- 035 __
- $a (PubMed)17426785
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xr
- 100 1_
- $a Stejskal, David, $d 1967- $7 xx0042302 $u Department of Laboratory Medicine and Internal Department, Sternberk Hospital
- 245 10
- $a Our experiences with measurement of new potential biomarkers in the diagnosis of latent forms of myocardial ischemia / $c D. Stejskal, B. Lacnak, M. Karpisek, M. Kaminek
- 520 9_
- $a BACKGROUND: The need for a laboratory marker of myocardial ischemia has been alluded to for at least the last decade. AIM: The aim of this study was to evaluate the diagnostic importance of the myosin light chain-1 (MLC-1), clusterin and Reg-Ialpha in patients with suspected myocardial ischemia. METHODS: A group of 176 at high-risk for myocardial ischemia subjects was evaluated and divided into two subgroups using myocardial SPECT (Single Photon Emission Computed Tomography) - individuals with and without signs of myocardial ischemia. Laboratory markers in venous blood were repeatedly examined in all subjects: a) immediately prior to SPECT: C-reactive protein, Haemoglobin, Hematocrite, Lactate, MLC-1, Clusterin, Reg-Ialpha b) at subjective maximum: Hb, Htc, lactate, MLC-1, Clusterin, Reg-Ialpha c) 30 min after stress levels reached their peak: MLC-1, Clusterin, Reg-Ialpha and d) 60 min after peak stress levels: MLC-1, Clusterin, Reg-Ialpha. RESULTS: Patients were divided into subgroups according to their positive and negative SPECT results (positive: n = 37; negative: n = 139). MLC-1 values were different for all 4 blood collections. An increase in MLC-1 > 2.2 mg/l showed 64 % sensitivity and 88 % specificity for the diagnosed presence of myocardial ischemia (AUC 0.81; LR+ 5.9; PPV+ 68 % and NPV- 87 %). There was no significant difference between the groups in terms of Clusterin and Reg-Ialpha for any of the sampling periods. CONCLUSIONS: High diagnostic efficacy of detectable MLC-1 was shown for the diagnosis of latent myocardial ischemia. Measurement of serum Clusterin or Reg-Ialpha did not sufficient for the diagnosis of latent myocardial ischemia.
- 650 _2
- $a biologické markery $x krev $7 D015415
- 650 _2
- $a klusterin $x krev $7 D051152
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a lithostatin $x krev $7 D051847
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a ischemická choroba srdeční $x diagnóza $7 D017202
- 650 _2
- $a lehké řetězce myosinu $x krev $7 D018994
- 650 _2
- $a senzitivita a specificita $7 D012680
- 650 _2
- $a jednofotonová emisní výpočetní tomografie $7 D015899
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Lačňák, Bořek $7 xx0062287 $u Department of Laboratory Medicine and Internal Department, Sternberk Hospital
- 700 1_
- $a Karpíšek, Michal $7 xx0107472 $u University of Veterinary and Pharmaceutical Sciences, Brno
- 700 1_
- $a Kamínek, Milan, $d 1965- $7 xx0035550 $u Department of Nuclear Medicine, Faculty of Medicine and Dentistry, Palacky University Olomouc
- 773 0_
- $w MED00012606 $t Biomedical papers of the Medical Faculty of the University Palacký, Olomouc, Czech Republic $x 1213-8118 $g Roč. 150, č. 2 (2006), s. 239-244
- 910 __
- $a ABA008 $b A 1502 $c sign $y 3 $z 0
- 990 __
- $a 20130128 $b ABA008
- 991 __
- $a 20130213090652 $b ABA008
- 999 __
- $a ok $b bmc $g 966328 $s 801867
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2006 $b 150 $c 2 $d 239-244 $i 1213-8118 $m Biomedical papers of the Medical Faculty of the University Palacký, Olomouc Czech Republic $n Biomed. Pap. Fac. Med. Palacký Univ. Olomouc Czech Repub. (Print) $x MED00012606
- LZP __
- $b NLK111 $a Pubmed-20130128